1. Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis
    Rebecca Rogier et al, 2017, Sci Rep CrossRef
  2. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils
    Mieke De Buck et al, 2015, Journal of Leukocyte Biology CrossRef
  3. Response Predictors to Calcineurin Inhibitors in Patients with Primary Membranous Nephropathy
    Xiaofang Yu et al, 2018, Am J Nephrol CrossRef
  4. Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project
    Daniela Braconi et al, 2018, Osteoarthritis and Cartilage CrossRef
  5. Associations between disease activity, markers of HDL functionality and arterial stiffness in patients with rheumatoid arthritis
    Eliana Botta et al, 2016, Atherosclerosis CrossRef
  6. Acute phase reactant serum amyloid A in inflammation and other diseases
    Yan Zhang et al, 2019 CrossRef
  7. The prognostic value of serum amyloid A for long-term mortality among patients with subclinical carotid atherosclerosis
    Florian J. Mayer et al, 2019, Eur J Clin Invest CrossRef
  8. ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation
    Debbie M. Boeters et al, 2019, Arthritis Res Ther CrossRef
  9. Amyloidosis of tongue and buccal mucosa: a case report
    Loganathan Kavitha et al, 2019, ClinicalDent CrossRef
  10. Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study
    Masaru Kato et al, 2019, Modern Rheumatology CrossRef
  11. The possible role of heat shock protein-70 induction in collagen-induced arthritis in rats
    MH El-Saka et al, 2019, Physiology International CrossRef
  12. An involvement of SR-B1 mediated p38 MAPK signaling pathway in serum amyloid A-induced angiogenesis in rheumatoid arthritis
    Chengcheng Hong et al, 2015, Molecular Immunology CrossRef
  13. Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker
    Yong Gil Hwang et al, 2016, Arthritis Res Ther CrossRef
  14. Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis
    Jihyung Yoo et al, 2017, Arthritis Res Ther CrossRef
  15. Metabolic Programming of Macrophages: Implications in the Pathogenesis of Granulomatous Disease
    Jayne Louise Wilson et al, 2019, Front. Immunol. CrossRef
  16. Serum amyloid A levels in patients with liver diseases
    Zi-Ying Yuan et al, 2019, WJG CrossRef
  17. Correlation of serum amyloid A levels, clinical manifestations, treatment, and disease activity in patients with acute anterior uveitis
    Ma-Li Dai et al, 2019, Eye CrossRef
  18. Detection of Citrullinated Fibrin in Plasma Clots of Rheumatoid Arthritis Patients and Its Relation to Altered Structural Clot Properties, Disease-Related Inflammation and Prothrombotic Tendency
    Johannes A. Bezuidenhout et al, 2020, Front. Immunol. CrossRef
  19. Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker
    Iva Sorić Hosman et al, 2021, Front. Immunol. CrossRef
  20. Gut-microbiota modulation: The impact of the gut-microbiota on osteoarthritis
    Vipin Arora et al, 2021, Gene CrossRef
  21. A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis
    Federica Ciregia et al, 2021, Front. Immunol. CrossRef
  22. Identification of Novel Serum Proteins Associated with Myelination and Cholesterol Transport in Neuromyelitis Optica Spectrum Disorders by Mass Spectrometry
    Mathew John et al, 2021, Ind J Clin Biochem CrossRef
  23. Pro-Inflammatory Serum Amyloid a Stimulates Renal Dysfunction and Enhances Atherosclerosis in Apo E-Deficient Mice
    Antony Gao et al, 2021, IJMS CrossRef
  24. Ratio of serum amyloid A to C‐reactive protein is constant in the same patients but differs greatly between patients with inflammatory diseases
    Osamu Saiki et al, 2021, Scand J Immunol CrossRef
  25. Discrepancy between SAA and CRP levels linked to the difference of SAA/CRP ratio in the patients with early rheumatoid arthritis
    Hiroshi Uda et al, 2021 CrossRef
  26. Treatment of Cardiovascular Disease in Rheumatoid Arthritis: A Complex Challenge with Increased Atherosclerotic Risk
    Saba Ahmed et al, 2021, Pharmaceuticals CrossRef
  27. iTRAQ‐based proteomic analysis of differentially expressed proteins in sera of seronegative and seropositive rheumatoid arthritis patients
    Yujue He et al, 2021, Clinical Laboratory Analysis CrossRef
  28. Association between serum amyloid A and rheumatoid arthritis: a systematic review and meta-analysis
    Jielin Zhou et al, 2021, Seminars in Arthritis and Rheumatism CrossRef
  29. Meta-Analysis of Effect in Serum Bio-Markers for Early Diagnosis: Rheumatoid Arthritis
    Myoung Soo Woo et al, 2021, Biomed Sci Letters CrossRef
  30. Analysis of rheumatoid factor and acute phase proteins using microarrays in patients with rheumatoid arthritis
    G. U. Feyzkhanova et al, 2022, Klin. lab. diagn. CrossRef
  31. Serum amyloid A-to-albumin ratio as a potential biomarker to predict the activity, severity, and poor prognosis of systemic lupus erythematosus.
    Liang Zhao et al, 2022, J Clin Lab Anal CrossRef
  32. Adaptation of Microarray Assay for Serum Amyloid a Analysis in Human Serum
    O. V. Smoldovskaya et al, 2022, Mol Biol CrossRef
  33. Cedrol from ginger alleviates rheumatoid arthritis through dynamic regulation of intestinal microenvironment
    Yumeng Zhang et al, 2022, Food Funct. CrossRef
  34. Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies
    Daniela Braconi et al, 2022, Cells CrossRef
  35. Inflammatory markers in rheumatic diseases
    A. S. Avdeeva, 2022, Naučno-praktičeskaâ revmatologiâ CrossRef
  36. Serum amyloid a level and musculoskeletal ultrasound in assessment of disease activity in rheumatoid arthritis patients
    Mai A. El Kosaier et al, 2023, The Egyptian Rheumatologist CrossRef
  37. Serum amyloid A and metabolic disease: evidence for a critical role in chronic inflammatory conditions
    Laura J. den Hartigh et al, 2023, Front. Cardiovasc. Med. CrossRef
  38. Role of Liquid Biopsies in Rheumatoid Arthritis
    Lin Bo et al, 2023 CrossRef
  39. SAA as Inflammatory Marker in Rheumatoid Arthritis: Study on Standard Therapy and Moringa Extract
    Yan Ajie Nugroho et al, 2023, Indonesian J. Clin. Pathol. Med. Lab. CrossRef
  40. Serum amyloid A facilitates expansion of CD4+ T cell and CD19+ B cell subsets implicated in the severity of myasthenia gravis patients
    Xiaoyu Huang et al, 2024, Journal of Neurochemistry CrossRef
  41. Serum amyloid A expression in liver promotes synovial macrophage activation and chronic arthritis via NFAT5
    Meiling Li et al, 2024 CrossRef
  42. The potential role of serum amyloid A as biomarker of rheumatic diseases: a systematic review and meta-analysis
    Angelo Zinellu et al, 2024, Clin Exp Med CrossRef
  43. Cyclic Nitroxide 4-Methoxy-Tempo May Decrease Serum Amyloid A-Mediated Renal Fibrosis and Reorganise Collagen Networks in Aortic Plaque
    Antony Gao et al, 2024, IJMS CrossRef